Incidence and risk factors for verrucae in women
- 19 June 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 22 (10), 1213-1219
- https://doi.org/10.1097/qad.0b013e3283021aa3
Abstract
Objectives: To describe the incidence and risk factors for verrucae in HIV-infected and uninfected women. Design and methods: A prospective study of 1790 HIV-infected and 772 uninfected women. Skin examinations and interviews were performed every 6 months over an 8-year study period. Data collected at each visit included antiretroviral therapy use since the prior visit, CD4 counts, HIV RNA loads, and location, description, and diagnosis of verrucae. Incidence rates of cutaneous and anogenital warts were determined. Results: Unadjusted cumulative incidence of cutaneous warts for HIV-uninfected women was 6.6%, 6.7% for HIV-infected women who initiated HAART, and 8.4% for HIV-infected, HAART-naïve women. The unadjusted cumulative incidence of anogenital verrucae for HIV-uninfected women was 9.3%, 28.4% for HIV-infected women who initiated HAART, and 25.1% for HIV-infected women who were HAART-naïve. Multivariate proportional hazard models revealed the following significant factors for the development of cutaneous verrucae among HIV-infected women: Black race [relative hazard (RH) = 0.50] and Hispanic ethnicity (RH = 0.38), compared to White race. Risk factors for anogenital verrucae were: more recent recruitment (RH = 0.63), human papillomavirus infection at baseline (RH = 1.85), decade of age (RH = 0.82), current smoker (RH = 1.40), lowest CD4 count (per 100 cells/μl) in the past 4 years (RH = 0.85), and log10 higher HIV viral load at the prior visit (RH = 1.34). Conclusion: HIV-infected women had a significantly increased cumulative incidence of anogenital verrucae compared to HIV-uninfected women. Although HAART did not alter the risk of developing skin or anogenital warts, those with higher CD4 cell counts and lower HIV RNA levels had a lower risk of developing anogenital warts.Keywords
This publication has 31 references indexed in Scilit:
- Skin Disease in HIV-Positive Persons Living in Puerto RicoAdvances in Skin & Wound Care, 2007
- The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the BenchClinical and Vaccine Immunology, 2005
- Highly Active Antiretroviral Therapy and Cervical Squamous Intraepithelial Lesions in Human Immunodeficiency Virus-Positive WomenJNCI Journal of the National Cancer Institute, 2004
- The changing pattern of Kaposi sarcoma in patients with HIV, 1994–2003Cancer, 2004
- Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virusAmerican Journal of Obstetrics and Gynecology, 2004
- Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2001
- Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency Virus-Infected AdultsJNCI Journal of the National Cancer Institute, 2000
- Selection by Indication of Potent Antiretroviral Therapy Use in a Large Cohort of Women Infected with Human Immunodeficiency VirusAmerican Journal of Epidemiology, 2000
- The Womenʼs Interagency HIV StudyEpidemiology, 1998
- Sexual Behavior and Partner Characteristics Are the Predominant Risk Factors for Genital Human Papillomavirus Infection in Young WomenThe Journal of Infectious Diseases, 1996